O&

Oscar & Paul

Europe, Hamburg, Germany, Hamburg

Description

Oscar & Paul operates as a corporate venture capital firm of Beiersdorf.

Investor Profile

Oscar & Paul has made 3 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series C (33%)

Country Focus

  • United States (67%)
  • France (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Artificial Intelligence (Ai)
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oscar & Paul frequently co-invest with?

Italian Angels for Growth
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Relyens
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1
YZR Capital
Europe, Bayern, Germany, Munich
Co-Investments: 1
Prunay
Europe, Ile-de-France, France, Louveciennes
Co-Investments: 1
TG
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Co-Investments: 1
Beiersdorf
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Ahren Innovation Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Hevolution
Asia, Ar Riyad, Saudi Arabia, Riyadh
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Oscar & Paul?

DeepLife

Vernon, Centre, France

DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

Artificial Intelligence (AI)BiotechnologyMachine Learning
Series ADec 11, 2024
Amount Raised: $10,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Rubedo Life Sciences

Sunnyvale, California, United States

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

BiotechnologyHealth CareLife Science
Series AApr 22, 2024
Amount Raised: $40,000,000